What’s Driving Growth in the Chorionic Gonadotropin Market? Insights into Key Trends and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Anticipated CAGR of the Chorionic Gonadotropin Market, and What Factors Will Drive It?
Over the recent years, the market size of chorionic gonadotropin has been experiencing stable growth. The industry forecast suggests that its expansion will continue in the forthcoming years, advancing from $1,260 million in 2024 to $1,340 million in 2025, reflecting a compound annual growth rate (CAGR) of 4.4%. The growth seen in the historical timeframe is the result of factors such as a higher level of understanding of hCG among patients and healthcare professionals, an increase in its use for treating hormonal imbalance disorders, making it more affordable, healthcare facility improvements, and a spiraling demand in the assisted reproduction sector.
The size of the chorionic gonadotropin market is anticipated to experience consistent growth in the forthcoming years. It’s projected to expand to $1,710 million in 2029 at a 4% compound annual growth rate (CAGR). This growth during the predicted period can be ascribed to factors such as a growing prevalence of fertility complications, heightened consciousness about reproductive health, accelerated adoption of assisted reproductive methods, an uptick in cases of hypogonadism in older individuals, and the growth of the healthcare infrastructure. Key trends to watch during this period are technological innovations, advances in recombinant methodologies, expansion in assisted reproductive technologies, monetary investments in research and development, and breakthroughs in medicinal delivery systems and formulations.
What Are the Primary Drivers Supporting the Growth of the Chorionic Gonadotropin Market?
The chorionic gonadotropin market is projected to grow due to an increased incidence of infertility problems. Infertility, defined as the inability for a couple under 35 years old to conceive after a year of regular, unprotected sex, or after six months for those above 35, is becoming more common. Factors contributing to this increase include delayed childbearing due to lifestyle choices and health issues such as obesity and smoking. Chorionic Gonadotropin (hCG) is often used in fertility treatments to stimulate ovulation, support pregnancy, and boost testosterone production to enhance sperm count, thus addressing different infertility issues. As per the figures released by the World Health Organization (WHO) in April 2023, approximately 17.5% of the global adult populace, or 1 in 6 individuals, struggle with infertility. This stresses the need for low-cost, high-quality fertility services. Consequently, these burgeoning infertility issues are propelling the growth of the chorionic gonadotropin market.
Explore Comprehensive Insights Into The Global Chorionic Gonadotropin Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19888&type=smp
Who Are the Top Companies Contributing to the Growth of the Chorionic Gonadotropin Market?
Major companies operating in the chorionic gonadotropin market include Ferring Pharmaceuticals
How Are Technological Trends Affecting the Growth and Development of the Chorionic Gonadotropin Market?
A prominent trend in the chorionic gonadotropin market is a strong focus on the development of forward-thinking solutions like saliva-based pregnancy tests that heighten convenience, precision, and reachability. A saliva-based pregnancy test utilizes a non-invasive way to diagnose pregnancy, by examining a woman’s saliva for human chorionic gonadotropin (hCG), a hormone secreted during pregnancy. For example, Salignostics, an Israeli biotech firm, introduced the world’s first saliva-based pregnancy test in June 2023. This novel product gives women the option to use a saliva sample to confirm pregnancy instead of urine, detecting the hCG (human chorionic gonadotropin) hormone with results ready within a short span of 5 to 15 minutes. Salistick provides a more relaxed and handy test experience, making it possible for users to perform the test anywhere and include their partners or family during this momentous occasion.
Secure Your Global Chorionic Gonadotropin Market Report Now for Fast and Efficient Delivery!
https://www.thebusinessresearchcompany.com/report/chorionic-gonadotropin-global-market-report
Which Segments of the Chorionic Gonadotropin Market Hold the Most Potential for Future Development?
The chorionic gonadotropinmarket covered in this report is segmented –
1) By Type: Human Chorionic Gonadotropin; Animal Chorionic Gonadotropin
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Therapeutic Application: Male Hypogonadism; Female Infertility Treatment; Oligospermic Treatment; Cryptorchidism Treatment; Chronic Pain; Other Therapeutic Applications
4) By End User: Research Institutions; Pharmaceutical Companies
What Are the Key Regions Powering Growth in the Chorionic Gonadotropin Market?
North America was the largest region in the chorionic gonadotropin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Defines the Scope of the Chorionic Gonadotropin Market?
Chorionic gonadotropin, specifically human chorionic gonadotropin (hCG), is a hormone produced by the placenta during pregnancy that supports the corpus luteum to maintain progesterone levels. It is used in medical treatments to induce ovulation in women, treat hypogonadism in men, and as a tumor marker for certain cancers.
Browse Through More Similar Reports By The Business Research Company:
Rheumatoid Arthritis Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report
Arthritis Monoclonal Antibodies Global Market Report 2025
Global Biosimilar Hormones Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: